Filter News
Area of Research
- (-) Supercomputing (44)
- Advanced Manufacturing (8)
- Biological Systems (1)
- Biology and Environment (30)
- Clean Energy (88)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (2)
- Electricity and Smart Grid (3)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (2)
- Fusion and Fission (32)
- Fusion Energy (13)
- Isotope Development and Production (1)
- Isotopes (27)
- Materials (97)
- Materials Characterization (2)
- Materials for Computing (14)
- Materials Under Extremes (1)
- National Security (23)
- Neutron Science (33)
- Nuclear Science and Technology (40)
- Nuclear Systems Modeling, Simulation and Validation (2)
- Quantum information Science (1)
- Sensors and Controls (2)
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (17)
- (-) Grid (5)
- (-) Isotopes (1)
- (-) Materials (15)
- (-) Nuclear Energy (4)
- (-) Security (5)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (5)
- Artificial Intelligence (36)
- Big Data (19)
- Bioenergy (9)
- Biology (11)
- Biotechnology (2)
- Buildings (4)
- Chemical Sciences (5)
- Climate Change (17)
- Computer Science (95)
- Coronavirus (14)
- Critical Materials (3)
- Cybersecurity (8)
- Decarbonization (5)
- Energy Storage (8)
- Environment (21)
- Exascale Computing (22)
- Frontier (28)
- Fusion (1)
- High-Performance Computing (38)
- Machine Learning (14)
- Materials Science (16)
- Mathematics (1)
- Microscopy (7)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (8)
- Net Zero (1)
- Neutron Science (13)
- Partnerships (1)
- Physics (7)
- Polymers (2)
- Quantum Computing (19)
- Quantum Science (24)
- Simulation (14)
- Software (1)
- Summit (42)
- Sustainable Energy (10)
- Transportation (6)
Media Contacts
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.
Neuromorphic devices — which emulate the decision-making processes of the human brain — show great promise for solving pressing scientific problems, but building physical systems to realize this potential presents researchers with a significant
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Twenty-seven ORNL researchers Zoomed into 11 middle schools across Tennessee during the annual Engineers Week in February. East Tennessee schools throughout Oak Ridge and Roane, Sevier, Blount and Loudon counties participated, with three West Tennessee schools joining in.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
ORNL researchers have developed an intelligent power electronic inverter platform that can connect locally sited energy resources such as solar panels, energy storage and electric vehicles and smoothly interact with the utility power grid.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.